{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T14:02:52Z","timestamp":1760623372375,"version":"build-2065373602"},"reference-count":41,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Objective: Heart failure affects 1\u20132% of the population in developed countries. Hemogram biomarkers are cheap, rapid, readily accessible and are known to have prognostic benefit in cardiovascular, infectious and oncologic diseases. Methods: The aim of the current study is to evaluate lymphocyte-to-white-blood-cell ratio (LWR) as a prognostic predictor in patients with heart failure. Patients with heart failure were recruited between January 2000 and July 2001. Exclusion criteria included metastatic malignancy, exposure to chemotherapy, radiotherapy or medications known to affect complete blood count. Results: 338 patients were enrolled, 33 were excluded. Mean age was 70.1 \u00b1 10.8, 225 patients were male (73%) and 80 were female (27%). All patients were divided into three groups according to LWR. Group 1 &lt; 0.2, group 2\u20140.2 &lt; LWR &lt; 0.35 and group 3 &gt; 0.35. Patients with LWR ratio &lt; 0.2 had the poorest survival while patients in the highest LWR (ratio &gt; 0.35) had the best long-term survival. Conclusions: Patients with congestive heart failure and LWR &lt; 0.2 showed significant increased mortality. LWR was shown as independent prognostic predictor for HF patients compared to other main outcome parameters, including CRP, NYHA, EF and LDL.<\/jats:p>","DOI":"10.3390\/life14101266","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T06:23:18Z","timestamp":1728282198000},"page":"1266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lymphocyte to White Blood Cell Count Ratio an Independent Risk Factor for Heart Failure"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-5193","authenticated-orcid":false,"given":"Lior","family":"Charach","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Laniado Medical Center, Netanya 4244916, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6551-9338","authenticated-orcid":false,"given":"Avishay","family":"Spitzer","sequence":"additional","affiliation":[{"name":"Oncology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv 6423906, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lior","family":"Zusmanovitch","sequence":"additional","affiliation":[{"name":"Meuhedet Health Service, Tel-Aviv 6473813, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Charach","sequence":"additional","affiliation":[{"name":"Holon Institute of Technology Israel, Holon 5810201, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Fr\u0105k, W., Wojtasi\u0144ska, A., and Lisi\u0144ska, W. (2022). Pathophysiology of cardiovascular diseases: New insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081938"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: Recent developments","volume":"185","author":"Lusis","year":"2022","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ehf2.13717","article-title":"Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction","volume":"9","author":"Fayol","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cardfail.2021.03.003","article-title":"Universal definition and classification of heart failure: Is it universal? Does it define heart failure?","volume":"27","author":"Lam","year":"2021","journal-title":"J. Card. Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jchf.2017.08.011","article-title":"Refining classification of heart failure based on ejection fraction","volume":"5","author":"Fonarow","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/ehf2.13424","article-title":"Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction","volume":"8","author":"Curran","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.amjcard.2014.10.008","article-title":"Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure","volume":"115","author":"Hernandez","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/erc.12.159","article-title":"Neutrophil to lymphocyte ratio and cardiovascular diseases: A review","volume":"11","author":"Bhat","year":"2013","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_10","first-page":"606","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of heart failure","volume":"105","author":"Durmus","year":"2015","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1586\/14737159.3.5.525","article-title":"Biomarkers: Current perspectives and future prospects","volume":"3","author":"Naylor","year":"2003","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e007849","DOI":"10.1161\/JAHA.117.007849","article-title":"Role of monocytes in heart failure and atrial fibrillation","volume":"7","author":"Shahid","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","article-title":"The three human monocyte subsets: Implications for health and disease","volume":"53","author":"Wong","year":"2012","journal-title":"Immunol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s42399-023-01570-5","article-title":"Selection of monocyte-to-lymphocyte ratio (MLR) or lymphocyte-to-monocyte ratio (LMR) as best prognostic tool in heart failure: A systematic review","volume":"5","author":"Vakhshoori","year":"2023","journal-title":"SN Compr. Clin. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Frosteg\u00e5rd, J. (2013). Immunity, atherosclerosis and cardiovascular disease. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-117"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/ATVBAHA.114.305144","article-title":"Lymphocytes in atherosclerosis","volume":"35","author":"Hedrick","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.2174\/092986711796391633","article-title":"Low lymphocyte count and cardiovascular diseases","volume":"18","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.amjcard.2010.12.049","article-title":"Usefulness of total lymphocyte count as predictor of outcome in patients with chronic heart failure","volume":"107","author":"Charach","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1067\/mhj.2001.115792","article-title":"Relative lymphocyte count: A prognostic indicator of mortality in elderly patients with congestive heart failure","volume":"142","author":"Acanfora","year":"2001","journal-title":"Am. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/y04-072","article-title":"\u03b2-adrenergic receptor blockade during exercise decreases intestinal lymphocyte apoptosis but not cell loss in mice","volume":"82","author":"Marra","year":"2004","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"55809","DOI":"10.1074\/jbc.M411767200","article-title":"Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA","volume":"279","author":"Abrams","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.3748\/wjg.v29.i23.3678","article-title":"Lymphocyte-to-white blood cell ratio is associated with outcome in patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"29","author":"Zhang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8667054","DOI":"10.1155\/2022\/8667054","article-title":"Prognostic Value of Lymphocyte-to-White Blood Cell Ratio for In-Hospital Mortality in Infective Endocarditis Patients","volume":"2022","author":"Zhang","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhao, W., Wang, P., and Jia, H. (2017). Lymphocyte count or percentage: Which can better predict the prognosis of advanced cancer patients following palliative care?. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3498-8"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","article-title":"Neutrophil counts and cardiovascular disease","volume":"44","author":"Luo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Vakhshoori, M., Nemati, S., and Sabouhi, S. (2023). Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-023-03572-6"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e17108","DOI":"10.1097\/MD.0000000000017108","article-title":"Monocytes may be favorable biomarker and predictor of long-term outcome in patients with chronic heart failure: A cohort study","volume":"98","author":"Charach","year":"2019","journal-title":"Medicine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.numecd.2015.07.004","article-title":"The lymphocyte-to-monocyte ratio: An added value for death prediction in heart failure","volume":"25","author":"Silva","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.amjcard.2010.09.039","article-title":"Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure","volume":"107","author":"Uthamalingam","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kim, J.H., Lim, S., and Park, K.S. (2017). Total and differential WBC counts are related with coronary artery atherosclerosis and increase the risk for cardiovascular disease in Koreans. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180332"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1076029614531449","article-title":"White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease","volume":"21","author":"Kounis","year":"2015","journal-title":"Clin. Appl. Thromb.\/Hemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/2047487319870344","article-title":"Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies","volume":"27","author":"Aimo","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11739-021-02637-8","article-title":"Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: A retrospective cohort study","volume":"16","author":"Pitre","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s41999-018-0051-5","article-title":"Lymphocyte-to-white blood cells ratio in older patients experiencing a first acute heart failure hospitalization","volume":"9","author":"Formiga","year":"2018","journal-title":"Eur Geriatr Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.hfc.2008.01.009","article-title":"The cholesterol paradox revisited: Heart failure, systemic inflammation, and beyond","volume":"4","author":"Schefold","year":"2008","journal-title":"Heart Fail. Clin."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejheart.2005.04.015","article-title":"Usefulness of anti-oxidized LDL antibody determination for assessment of clinical control in patients with heart failure","volume":"8","author":"George","year":"2006","journal-title":"Eur. J. Heart Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2010.05.049","article-title":"Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation","volume":"56","author":"Smith","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","article-title":"C-reactive protein in heart failure: Prognostic value and the effect of valsartan","volume":"112","author":"Anand","year":"2005","journal-title":"Circulation"},{"key":"ref_40","first-page":"796","article-title":"Proteomics reveals high levels of vitamin D binding protein in myocardial infarction","volume":"2","author":"Gasparri","year":"2010","journal-title":"Front Biosci Elite Ed"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.amjcard.2013.05.014","article-title":"Plasma vitamin D-binding protein and risk of heart failure in male physicians","volume":"112","author":"Petrone","year":"2013","journal-title":"Am. J. Cardiol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/10\/1266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:10:57Z","timestamp":1760112657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/10\/1266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,5]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["life14101266"],"URL":"https:\/\/doi.org\/10.3390\/life14101266","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2024,10,5]]}}}